The global melatonin supplement market experienced significant price fluctuations during 2025 and early 2026. While prices generally trended upward due to growing demand for sleep-support supplements, manufacturers and distributors also faced periods of oversupply, inventory corrections, and changing purchasing behavior.
Melatonin has become one of the most widely consumed sleep ingredients globally. Demand continues to rise as consumers increasingly focus on sleep quality, stress management, wellness, and preventive healthcare. This sustained demand has helped support prices despite temporary market slowdowns.
During 2025, industrial-grade melatonin prices reached some of their highest levels in several key markets before softening toward the end of the year. By early 2026, tightening supply conditions and rising raw material costs began supporting prices once again.
Key Price Data
| Period | Region | Average Melatonin Price |
|---|---|---|
| Q1 2025 | China | $73,378/MT |
| Q1 2025 | Canada | $76,164/MT |
| Q1 2025 | France | $79,626/MT |
| Q1 2025 | Spain | $87,936/MT |
| Q2 2025 | USA | $92,500/MT FOB |
| Q4 2025 | USA | $89,275/MT |
| Q4 2025 | China | $61,748/MT |
| Early 2026 | Global Industrial Market | $63–91/kg |
What Drove Melatonin Prices Higher?
1. Rising Consumer Demand
Consumer demand remains the biggest factor influencing melatonin pricing.
Sleep supplements have become one of the fastest-growing segments within the global nutraceutical industry. Consumers are increasingly purchasing melatonin products to support sleep quality, manage stress, address jet lag, and improve overall wellness.
The U.S. melatonin supplement market generated approximately $684 million in sales during the first four months of 2026, compared with roughly $629 million during the same period in 2025. This growth reflects strong consumer adoption across retail stores, pharmacies, and e-commerce channels.
Demand is being supported by:
- Growing awareness of sleep health
- Stress and anxiety management products
- Shift-work and jet-lag solutions
- Increasing adoption among Millennials and Gen Z
Notably, approximately 61% of melatonin buyers belong to the Millennial and Gen Z population, highlighting the growing role younger consumers are playing in driving long-term market expansion.
2. Raw Material Cost Inflation
Production costs also increased throughout the supply chain.
Melatonin manufacturing relies on specialized pharmaceutical intermediates and chemical precursors, including compounds derived from L-tryptophan and indole chemistry. Any disruption in the availability of these raw materials directly impacts production costs.
During early 2026, supply constraints affecting pharmaceutical-grade L-tryptophan reportedly pushed precursor costs approximately 18% higher. Manufacturers were forced to absorb part of these increases while passing some costs downstream to supplement brands and distributors.
As raw material costs rise, profit margins become increasingly dependent on operational efficiency and supply-chain management.
3. Logistics and Supply Chain Pressures
Global supply-chain challenges continued to affect pricing throughout 2025 and into 2026.
Melatonin producers faced:
- Higher transportation expenses
- Regulatory inspections
- Import delays
- Export restrictions on certain precursors
Many manufacturers also encountered longer lead times for pharmaceutical-grade ingredients and packaging materials. These disruptions increased procurement costs and contributed to upward pressure on finished melatonin prices in several regions.
Melatonin Supplement Price Snapshot (2026)
| Brand/Product | Melatonin Strength | Pack Size | Retail Price |
|---|---|---|---|
| GNC Melatonin 3 mg | 3 mg | 120 Tablets | ₹798 |
| Pure Nutrition Melatonin 5mg Veg Tablets | 5 mg | Standard Pack | ₹389 |
| Briyo Melatonin Chewable Tablets | 3 mg | 50 Tablets | ₹286 |
| Inlife Melatonin Tablets | 5 mg | Standard Pack | ₹449 |
| Nature’s Bounty Melatonin Softgels | 5 mg | Softgel Pack | ₹1,899 |
| Carbamide Forte Melatonin + Tagar | 5 mg | Sleep Support Tablets | ₹539 |
| Dr. Morepen Sleep Supplement | 3 mg | Tablet Pack | ₹695 |
| OLLY Extra Strength Sleep | Multi-Ingredient | Fast Dissolve Tablets | ₹2,219 |
Get real-time enterprise insights with our FREE Sample, offering region-wise stats, numbers, and complete market data for informed business decisions. Download Now: https://www.towardshealthcare.com/download-sample/6727
Why Did Prices Fall in Late 2025?
Despite strong long-term demand, melatonin prices declined during the final quarter of 2025.
United States
- Prices fell 1.73% quarter-over-quarter
- Inventories remained elevated
- Buyers delayed new procurement
Several supplement companies reduced purchasing activity after building large inventories earlier in the year, leading to temporary pricing pressure.
China
- Prices fell 2.44% quarter-over-quarter
- Export demand weakened
- Oversupply pressured the market
China remains one of the world’s most important production hubs for melatonin ingredients. When export demand slowed, suppliers responded by lowering prices to remain competitive.
Europe
- Major import hubs experienced roughly 11% quarter-over-quarter declines
European distributors focused on inventory reduction rather than new purchasing, resulting in lower transaction volumes and softer pricing.
Importantly, these declines were driven primarily by inventory corrections rather than a reduction in consumer demand.
What Decision Makers Should Watch
| Market Indicator | Why It Matters |
|---|---|
| Raw Melatonin Prices | Direct impact on ingredient procurement costs |
| L-Tryptophan Prices | Key precursor affecting manufacturing costs |
| Supplement Sales Growth | Indicates future ingredient demand |
| Inventory Levels | Excess inventory can temporarily depress prices |
| E-commerce Sales | Major growth channel for sleep supplements |
| Consumer Sleep Health Trends | Primary demand driver globally |
| Premium Product Launches | Support higher margins despite ingredient volatility |
2026 Market Outlook
Most industry observers expect melatonin prices to remain stable to moderately firm throughout 2026.
Several factors continue to support the market, including growing sleep supplement consumption, expanding e-commerce sales, increasing wellness spending, and rising demand for natural health products.
Supporting factors include:
- Continued growth in sleep supplement sales
- Strong pharmaceutical demand
- Rising wellness spending
- Expanding online supplement channels
Potential downside risks include:
- Inventory corrections
- New manufacturing capacity
- Lower raw-material costs
- Softer consumer spending
Recent market activity suggests that supply remains relatively tight. In North America, melatonin prices recorded a weekly increase of approximately 0.32% during March 2026, indicating that manufacturers are regaining pricing power as inventories normalize.
Decision-Maker Statistics
| Metric | Latest Data |
| U.S. Melatonin Market Sales (Jan–Apr 2026) | $684 Million |
| Industrial Melatonin Price Range (2026) | $63–91/kg |
| U.S. Q2 2025 Price | $92,500/MT |
| China Q4 2025 Price | $61,748/MT |
| U.S. Q4 2025 Price Decline | -1.73% QoQ |
| China Q4 2025 Price Decline | -2.44% QoQ |
| L-Tryptophan Cost Increase (2026) | ~18% |
| Millennials + Gen Z Share of Buyers | 61% |
What This Means for Buyers and Manufacturers
The melatonin market remains fundamentally supported by strong consumer demand and growing awareness of sleep health. While short-term price corrections may continue, the combination of increasing supplement consumption, higher raw material costs, and supply-chain pressures is likely to keep prices elevated compared with historical averages.
For supplement brands, ingredient manufacturers, distributors, and investors, monitoring raw material availability, inventory levels, and consumer demand trends will remain critical for navigating the market throughout 2026.
Access our exclusive, data-rich dashboard dedicated to the pharmaceutical industry – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Healthcare WebWire is a part of Towards Healthcare Research and Consulting provides strategic intelligence and research expertise across the pharmaceutical market, including branded drugs, generic medicines, biologics, biosimilars, specialty pharmaceuticals, OTC products, and drug delivery systems. We support pharmaceutical companies with market analysis, pipeline assessment, and competitive insights to help drive innovation, strengthen commercialization strategies, and capture emerging growth opportunities in the evolving healthcare landscape.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium